Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4331401)

Published in J Int AIDS Soc on February 16, 2015

Authors

Hinta Meijerink1, Rudi Wisaksana2,3, Mery Lestari3, Intan Meilana3, Lydia Chaidir2, Andre J A M van der Ven1, Bachti Alisjahbana2, Reinout van Crevel4

Author Affiliations

1: Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
2: Health Research Unit, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung, Indonesia.
3: Department of Internal Medicine, Faculty of Medicine, Hasan Sadikin Hospital, Padjadjaran University, Bandung, Indonesia.
4: Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands; Reinout.vanCrevel@radboudumc.nl.

Articles cited by this

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet (2002) 6.54

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49

Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis (2005) 5.20

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med (2005) 4.94

An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44

Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax (2004) 2.34

Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax (2007) 2.27

Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med (2010) 2.07

HIV infection-related tuberculosis: clinical manifestations and treatment. Clin Infect Dis (2010) 2.02

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis (2009) 2.01

Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest (1998) 1.79

Tuberculosis and illicit drug use: review and update. Clin Infect Dis (2009) 1.76

The effect of the host's iron status on tuberculosis. J Infect Dis (2007) 1.49

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status. Int J Tuberc Lung Dis (2008) 1.38

Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J (2005) 1.30

Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol (2006) 1.30

Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis (2006) 1.28

Prevention of infectious disease transmission in correctional settings: a review. Public Health (2005) 1.19

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. AIDS (2010) 1.19

Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS (2012) 1.18

Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am J Prev Med (1999) 1.18

Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14

HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002. Emerg Infect Dis (2007) 1.08

Yield of tuberculin screening among injection drug users. Int J Tuberc Lung Dis (2004) 1.06

Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. J Infect Dis (1998) 1.05

Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction (2010) 0.99

Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology (2014) 0.98

Tuberculosis infection in drug users: interferon-gamma release assay performance. Int J Tuberc Lung Dis (2007) 0.91

Critical role of toll-like receptor 9 in morphine and Mycobacterium tuberculosis-Induced apoptosis in mice. PLoS One (2010) 0.89

Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? Biochem Pharmacol (2003) 0.88

Co-occurrence of AIDS and tuberculosis: results of a database "match" and investigation. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.87

Characteristics of subjects counseled and tested for HIV in an Indonesian hospital; factors associated with HIV-status and CD4 cell-count. Acta Med Indones (2009) 0.83

Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia. J Int AIDS Soc (2014) 0.82

Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir. AIDS (2015) 0.78

Morphine alters M. bovis infected microglia's ability to activate γδ T lymphocytes. J Neuroimmune Pharmacol (2011) 0.77

Effect of morphine on Mycobacterium smegmatis infection in mice and macrophages. Indian J Microbiol (2009) 0.77

Factors associated with extrapulmonary tuberculosis as an AIDS-defining disease in Europe. The Coordinators of AIDS surveillance in Austria, Belgium, France, Germany, Italy, Portugal, Switzerland, United Kingdom and the city of Amsterdam. Tuber Lung Dis (1995) 0.77